Zealand Pharma major shareholder announcement: Van Herk Investments
Provided By Globe Newswire
Last update: Oct 10, 2022
Company announcement – No. 46 / 2022
Zealand Pharma major shareholder announcement: Van Herk Investments
Copenhagen, Denmark and Boston, MA, 10 October 2022 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the receipt of notification dated 10 October 2022 pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders:
Read more at globenewswire.com
